Boehringer Ingelheim International GmbH - Company Profile
Powered by
All the data and insights you need on Boehringer Ingelheim International GmbH in one report.
- Save hours of research time and resources with
our up-to-date Boehringer Ingelheim International GmbH Strategy Report
- Understand Boehringer Ingelheim International GmbH position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Boehringer Ingelheim International GmbH (Boehringer Ingelheim) is an innovative research based pharmaceutical company that discovers, develops, and markets novel products of high therapeutic value for human and veterinary use. Robust R&D and partnering program: BioXcellence are its strengths even as private ownership restricts ability to raise funds could be a major cause for concern for the company. Boehringer Ingelheim could benefit from strategic alliances, new product approvals and pipeline which provide growth opportunities to the company. However, adverse or inconclusive results from preclinical testing or clinical trials, influx of generics and government regulations could affect the company's operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer